Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
Pfizer (NYSE: PFE) has announced a conference call with investment analysts scheduled for 10:30 a.m. EST on Tuesday, February 4, 2025. The call will discuss Pfizer's Fourth Quarter and Full Year 2024 Performance Report, which will be released that morning.
Investors and the public can access the webcast through www.pfizer.com/investors. Participants can join via webcast or by phone using the following numbers: 800-456-4352 (US/Canada) or 785-424-1086 (International), with passcode '30674'. The webcast replay and transcript will be available within 24 hours after the call and accessible for at least 90 days on Pfizer's investor website.
Pfizer (NYSE: PFE) ha annunciato una conferenza telefonica con analisti finanziari programmata per alle 10:30 EST di martedì 4 febbraio 2025. La chiamata discuterà il Rapporto sulle Prestazioni del Quarto Trimestre e dell'Anno Intero 2024 di Pfizer, che sarà pubblicato quella mattina.
Gli investitori e il pubblico possono accedere alla trasmissione in diretta tramite www.pfizer.com/investors. I partecipanti possono unirsi tramite webcast o telefono utilizzando i seguenti numeri: 800-456-4352 (US/Canada) o 785-424-1086 (Internazionale), con il codice di accesso '30674'. La registrazione della trasmissione e la trascrizione saranno disponibili entro 24 ore dopo la chiamata e accessibili per almeno 90 giorni sul sito web per investitori di Pfizer.
Pfizer (NYSE: PFE) ha anunciado una llamada de conferencia con analistas de inversiones programada para las 10:30 a.m. EST del martes 4 de febrero de 2025. La llamada discutirá el Informe de Desempeño del Cuarto Trimestre y del Año Completo 2024 de Pfizer, que se publicará esa mañana.
Los inversores y el público pueden acceder a la transmisión en vivo a través de www.pfizer.com/investors. Los participantes pueden unirse a través de webcast o por teléfono utilizando los siguientes números: 800-456-4352 (US/Canadá) o 785-424-1086 (Internacional), con el código de acceso '30674'. La repetición de la transmisión y la transcripción estarán disponibles dentro de las 24 horas posteriores a la llamada y accesibles durante al menos 90 días en el sitio web de inversores de Pfizer.
화이자 (NYSE: PFE)는 2025년 2월 4일 화요일 오전 10:30 EST에 예정된 투자 분석가와의 컨퍼런스 콜을 발표했습니다. 이번 콜에서는 화이자의 2024년 4분기 및 전체 연도 실적 보고서에 대해 논의할 예정이며, 보고서는 그날 오전에 발표됩니다.
투자자와 대중은 www.pfizer.com/investors를 통해 웹캐스트에 접속할 수 있습니다. 참가자는 웹캐스트 또는 전화로 다음 번호를 통해 참여할 수 있습니다: 800-456-4352 (미국/캐나다) 또는 785-424-1086 (국제), 접속 코드 '30674'를 입력합니다. 웹캐스트 재생과 대본은 콜 후 24시간 이내에 제공되며, 화이자의 투자자 웹사이트에서 최소 90일 동안 접근할 수 있습니다.
Pfizer (NYSE: PFE) a annoncé une conférence téléphonique avec des analystes financiers prévue pour 10h30 EST le mardi 4 février 2025. L'appel discutera du Rapport de performance du Quatrième Trimestre et de l'Année 2024 de Pfizer, qui sera publié ce matin-là.
Les investisseurs et le public peuvent accéder au webinaire via www.pfizer.com/investors. Les participants peuvent rejoindre via le webinaire ou par téléphone en utilisant les numéros suivants : 800-456-4352 (États-Unis/Canada) ou 785-424-1086 (International), avec le code d'accès '30674'. La rediffusion du webinaire et la transcription seront disponibles dans les 24 heures suivant l'appel et accessibles pendant au moins 90 jours sur le site des investisseurs de Pfizer.
Pfizer (NYSE: PFE) hat eine Telefonkonferenz mit Anlageanalysten für 10:30 Uhr EST am Dienstag, den 4. Februar 2025 angekündigt. In der Konferenz wird der Leistungsbericht für das vierte Quartal und das gesamte Jahr 2024 von Pfizer besprochen, der an diesem Morgen veröffentlicht wird.
Investoren und die Öffentlichkeit können die Webkonferenz über www.pfizer.com/investors verfolgen. Teilnehmer können sich entweder über das Webcast oder telefonisch unter den folgenden Nummern einwählen: 800-456-4352 (USA/Kanada) oder 785-424-1086 (International), mit dem Zugangs-Code '30674'. Die Wiederholung des Webcasts und das Transkript werden innerhalb von 24 Stunden nach dem Anruf verfügbar sein und mindestens 90 Tage auf der Investoren-Website von Pfizer zugänglich sein.
- None.
- None.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call.
You can also listen to the conference call by dialing either 800-456-4352 in
The transcript and webcast replay of the call will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live conference call and will be accessible for at least 90 days.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections, reorganizations, business plans, strategy and prospects; our Environmental, Social and Governance (ESG) priorities, strategy and goals; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities; and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219400774/en/
Media
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
When is Pfizer's Q4 2024 earnings call (PFE)?
How can I listen to Pfizer's (PFE) Q4 2024 earnings call?
How long will Pfizer's (PFE) Q4 2024 earnings call replay be available?
What will be discussed in Pfizer's (PFE) February 4, 2025 conference call?
